NL1025933A1 - 4-Fenyl-piperidineverbindingen en de toepassing ervan als modulatoren van opioïde receptoren. - Google Patents
4-Fenyl-piperidineverbindingen en de toepassing ervan als modulatoren van opioïde receptoren.Info
- Publication number
- NL1025933A1 NL1025933A1 NL1025933A NL1025933A NL1025933A1 NL 1025933 A1 NL1025933 A1 NL 1025933A1 NL 1025933 A NL1025933 A NL 1025933A NL 1025933 A NL1025933 A NL 1025933A NL 1025933 A1 NL1025933 A1 NL 1025933A1
- Authority
- NL
- Netherlands
- Prior art keywords
- modulators
- phenyl
- opioid receptors
- piperidine compounds
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46265103P | 2003-04-14 | 2003-04-14 | |
| US46265103 | 2003-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL1025933A1 true NL1025933A1 (nl) | 2004-10-18 |
| NL1025933C2 NL1025933C2 (nl) | 2005-11-23 |
Family
ID=33159858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1025933A NL1025933C2 (nl) | 2003-04-14 | 2004-04-13 | 4-Fenyl-piperidineverbindingen en de toepassing ervan als modulatoren van opioïde receptoren. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20040204453A1 (nl) |
| EP (1) | EP1615643A1 (nl) |
| JP (1) | JP2006522792A (nl) |
| AR (1) | AR044016A1 (nl) |
| BR (1) | BRPI0409436A (nl) |
| CA (1) | CA2522214A1 (nl) |
| CL (1) | CL2004000695A1 (nl) |
| DO (1) | DOP2004000876A (nl) |
| GT (1) | GT200400064A (nl) |
| MX (1) | MXPA05011018A (nl) |
| NL (1) | NL1025933C2 (nl) |
| PA (1) | PA8600001A1 (nl) |
| PE (1) | PE20050416A1 (nl) |
| TW (1) | TW200423934A (nl) |
| UY (1) | UY28263A1 (nl) |
| WO (1) | WO2004089370A1 (nl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0213464A (pt) * | 2001-10-22 | 2004-11-09 | Pfizer Prod Inc | Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide |
| US7381721B2 (en) * | 2003-03-17 | 2008-06-03 | Adolor Corporation | Substituted piperidine compounds |
| BRPI0409307A (pt) | 2003-04-14 | 2006-04-25 | Pfizer Prod Inc | derivados de 3-azabiciclo[3.2.1]octano |
| US6992090B2 (en) * | 2003-06-16 | 2006-01-31 | Adolor Corporation | Substituted piperidine compounds and methods of their use |
| AR057061A1 (es) * | 2005-06-16 | 2007-11-14 | Altana Pharma Ag | Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos |
| MY145633A (en) * | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| TWI409067B (zh) | 2007-02-28 | 2013-09-21 | Theravance Inc | ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型 |
| US7691878B2 (en) * | 2007-08-27 | 2010-04-06 | Theravance, Inc. | Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| US7947710B2 (en) | 2007-08-27 | 2011-05-24 | Theravance, Inc. | Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| ES2390195T3 (es) * | 2007-08-27 | 2012-11-07 | Theravance, Inc. | Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu |
| TWI423801B (zh) * | 2007-08-27 | 2014-01-21 | Theravance Inc | 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物 |
| WO2013086496A2 (en) | 2011-12-09 | 2013-06-13 | Research Triangle Institute | 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists |
| EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA |
| US10441458B2 (en) | 2015-01-27 | 2019-10-15 | Medicance Incorporated | Medical pad and system for thermotherapy |
| AU2017325870B2 (en) | 2016-09-16 | 2021-07-22 | Research Traingle Institute | Tetrahydroisoquinoline kappa opioid antagonists |
| WO2018108319A1 (en) * | 2016-12-16 | 2018-06-21 | Laboratorios Del Dr. Esteve, S.A. | Tetrahydropyran and tetrahydrothiopyran amide derivatives having multimodal activity against pain |
| CA3050515A1 (en) * | 2017-01-17 | 2018-07-26 | Mebias Discovery, Inc. | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same |
| BR112019018774A2 (pt) * | 2017-03-12 | 2020-04-07 | Wang Xiaodong | composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer |
| US11584765B2 (en) | 2017-03-12 | 2023-02-21 | Ecstasy LLC | Polycyclic amines as sigma receptor modulators |
| BR112022026413A2 (pt) | 2020-07-01 | 2023-05-02 | Ecstasy LLC | Aminas policíclicas para modulação de receptores opióides. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4891379A (en) * | 1987-04-16 | 1990-01-02 | Kabushiki Kaisha Kobe Seikosho | Piperidine opioid antagonists |
| GB9912411D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| DE60302157T2 (de) * | 2002-05-30 | 2006-07-27 | Eli Lilly And Co., Indianapolis | Opioidrezeptorantagonisten |
| US7381721B2 (en) * | 2003-03-17 | 2008-06-03 | Adolor Corporation | Substituted piperidine compounds |
-
2004
- 2004-01-22 US US10/762,447 patent/US20040204453A1/en not_active Abandoned
- 2004-03-31 CL CL200400695A patent/CL2004000695A1/es unknown
- 2004-04-01 WO PCT/IB2004/001161 patent/WO2004089370A1/en active Application Filing
- 2004-04-01 MX MXPA05011018A patent/MXPA05011018A/es unknown
- 2004-04-01 CA CA002522214A patent/CA2522214A1/en not_active Abandoned
- 2004-04-01 BR BRPI0409436-0A patent/BRPI0409436A/pt not_active IP Right Cessation
- 2004-04-01 EP EP04725122A patent/EP1615643A1/en not_active Withdrawn
- 2004-04-01 JP JP2006506479A patent/JP2006522792A/ja not_active Abandoned
- 2004-04-02 DO DO2004000876A patent/DOP2004000876A/es unknown
- 2004-04-06 GT GT200400064A patent/GT200400064A/es unknown
- 2004-04-12 UY UY28263A patent/UY28263A1/es not_active Application Discontinuation
- 2004-04-12 PA PA20048600001A patent/PA8600001A1/es unknown
- 2004-04-12 PE PE2004000363A patent/PE20050416A1/es not_active Application Discontinuation
- 2004-04-13 AR ARP040101234A patent/AR044016A1/es unknown
- 2004-04-13 TW TW093110285A patent/TW200423934A/zh unknown
- 2004-04-13 NL NL1025933A patent/NL1025933C2/nl not_active IP Right Cessation
- 2004-04-13 US US10/823,026 patent/US20050032837A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050032837A1 (en) | 2005-02-10 |
| MXPA05011018A (es) | 2005-12-12 |
| GT200400064A (es) | 2004-11-30 |
| PE20050416A1 (es) | 2005-06-13 |
| WO2004089370A1 (en) | 2004-10-21 |
| EP1615643A1 (en) | 2006-01-18 |
| BRPI0409436A (pt) | 2006-04-18 |
| CL2004000695A1 (es) | 2005-02-04 |
| JP2006522792A (ja) | 2006-10-05 |
| AR044016A1 (es) | 2005-08-24 |
| CA2522214A1 (en) | 2004-10-21 |
| TW200423934A (en) | 2004-11-16 |
| US20040204453A1 (en) | 2004-10-14 |
| PA8600001A1 (es) | 2004-12-16 |
| DOP2004000876A (es) | 2004-10-15 |
| UY28263A1 (es) | 2004-11-30 |
| NL1025933C2 (nl) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL1025933A1 (nl) | 4-Fenyl-piperidineverbindingen en de toepassing ervan als modulatoren van opioïde receptoren. | |
| ECSP066436A (es) | Compuestos heterociclicos fusionados | |
| ATE391718T1 (de) | Phenylacetamide und ihre verwendung als glukokinase-modulatoren | |
| DK2298744T3 (da) | Opioid-receptor modulatorer | |
| DE602004015724D1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| DE602004024420D1 (de) | Chinazolinderivate als antitumormittel | |
| SI1587542T1 (sl) | Uporaba anti-cd100 protiteles | |
| ATE382261T1 (de) | Flüssige formulierung | |
| ATE491774T2 (de) | Benzinzusammensetzung | |
| FI20030261A (fi) | Iskulaite | |
| DE60322030D1 (de) | Lichtempfindliches element zur benutzung als flexodruckplatte | |
| DE502004009177D1 (de) | Poly-alpha-olefin-haltige kosmetische zusammensetzung | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| DE602004018858D1 (de) | Emulsionszusammensetzung | |
| ATE394372T1 (de) | G-lactamderivate als prostaglandinagonisten | |
| DE502004006233D1 (de) | Schubmaststapler | |
| ATE514681T1 (de) | N-substituierte pyrazolylcarboxanilide | |
| ATE411027T1 (de) | Benzazepin-derivate als mao-b-hemmer | |
| ATE455770T1 (de) | N-alkynyl-2-heteroaryloxyalkylamide zur verwendung als fungizide | |
| FR2879924B1 (fr) | Composition cosmetique amincissante | |
| FR2849788B1 (fr) | Melangeur | |
| FR2873658B1 (fr) | Coiffe de surbouchage de bouteilles | |
| ITBO20030102U1 (it) | Apparato di profumazione ambientale | |
| DE602004010223D1 (de) | Benzinzusammensetzung | |
| TH105710B (th) | โอพิออยด์รีเซปเตอร์แอนตะกอนิสต์ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AD1A | A request for search or an international type search has been filed | ||
| RD2N | Patents in respect of which a decision has been taken or a report has been made (novelty report) |
Effective date: 20050722 |
|
| PD2B | A search report has been drawn up | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20081101 |